Major Depressive Disorder | Hamilton rating scale for depression
Item
meet dsm-iv criteria for current major depression, and have a ham-d (21 item) score of > 17
boolean
C1269683 (UMLS CUI [1])
C0451203 (UMLS CUI [2])
Childbearing Potential Contraceptive methods | Contraceptives, Oral | Intrauterine Devices | Contraception, Barrier | Sexual Abstinence
Item
male or female who, if of child-bearing potential, agrees to use effective contraception including the regular use of contraceptive pills, intra-uterine devices, barrier methods or abstinence
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0009905 (UMLS CUI [2])
C0021900 (UMLS CUI [3])
C0004764 (UMLS CUI [4])
C0036899 (UMLS CUI [5])
Age
Item
age between 18 and 65
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
capable of giving informed consent
boolean
C0021430 (UMLS CUI [1])
Schizophrenia | Schizophreniform Disorders | Schizoaffective Disorder | Schizotypal disorder | Depression, psychotic | Bipolar Disorder
Item
diagnosis of schizophrenia, schizophreniform disorder, schizoaffective disorder, schizotypal disorder, psychotic depression or bipolar disorders
boolean
C0036341 (UMLS CUI [1])
C0036358 (UMLS CUI [2])
C0036337 (UMLS CUI [3])
C1443045 (UMLS CUI [4])
C0743072 (UMLS CUI [5])
C0005586 (UMLS CUI [6])
Substance Use Disorders | Substance Dependence
Item
current drug or alcohol abuse or dependence, or history of drug or alcohol abuse or dependence within the previous 6 months
boolean
C0038586 (UMLS CUI [1])
C0038580 (UMLS CUI [2])
medical condition Unstable Interferes with Therapeutic procedure Depressive disorder | Condition Neurologic Unstable Interferes with Therapeutic procedure Depressive disorder
Item
unstable medical or neurological conditions that are likely to interfere with the treatment of depression
boolean
C3843040 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C0011581 (UMLS CUI [1,5])
C0348080 (UMLS CUI [2,1])
C0205494 (UMLS CUI [2,2])
C0443343 (UMLS CUI [2,3])
C0521102 (UMLS CUI [2,4])
C0087111 (UMLS CUI [2,5])
C0011581 (UMLS CUI [2,6])
Hypersensitivity Citalopram | Hypersensitivity Proepa | Hypersensitivity Finfish | Hypersensitivity Shellfish
Item
history of allergy to citalopram or proepa, finfish or shellfish
boolean
C0020517 (UMLS CUI [1,1])
C0008845 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0722823 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0016163 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C1304606 (UMLS CUI [4,2])
Citalopram Dosage Unresponsive to Treatment
Item
history of failure of response to citalopram, as documented by an adequate trial of the medication [defined as having been treated with the medication at a dose level typically regarded as adequate (i.e., 40 mg of citalopram per day) for at least 6 weeks]
boolean
C0008845 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205269 (UMLS CUI [1,3])
Epilepsy
Item
history of seizure disorder
boolean
C0014544 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Psychotropic Drugs | Antidepressive Agents | Antipsychotic Agents
Item
currently on psychotropic medications including antidepressants or neuroleptics
boolean
C0033978 (UMLS CUI [1])
C0003289 (UMLS CUI [2])
C0040615 (UMLS CUI [3])
Feeling suicidal | Safety Problem
Item
active suicidal ideation or other safety issues determined by the clinician to not be suitable for inclusion in the study
boolean
C0424000 (UMLS CUI [1])
C0036043 (UMLS CUI [2,1])
C0033213 (UMLS CUI [2,2])
Fluoxetine Exposure to | Monoamine Oxidase Inhibitors Exposure to
Item
exposure to treatment with fluoxetine or maois in the previous two months
boolean
C0016365 (UMLS CUI [1,1])
C0332157 (UMLS CUI [1,2])
C0026457 (UMLS CUI [2,1])
C0332157 (UMLS CUI [2,2])
Anticoagulant therapy
Item
patients on anticoagulant therapy
boolean
C0150457 (UMLS CUI [1])
Omega-3 Fatty Acids Total Dietary intake
Item
patients with a dietary intake of > 3.0g total omega-3 pufa/day at baseline
boolean
C0015689 (UMLS CUI [1,1])
C0439810 (UMLS CUI [1,2])
C1286104 (UMLS CUI [1,3])